Rituximab: mechanisms and applications
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 2001-11, Vol.85 (11), p.1619-1623 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1623 |
|---|---|
| container_issue | 11 |
| container_start_page | 1619 |
| container_title | British journal of cancer |
| container_volume | 85 |
| creator | Johnson, P W M Glennie, M J |
| description | |
| doi_str_mv | 10.1054/bjoc.2001.2127 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2363990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72351605</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-a19e2c216ad44a67c8ec2d2dd87d2217ed9df51ff2bdd9930143e62a077cff353</originalsourceid><addsrcrecordid>eNp1kN1L5DAUxYO46Kj76qMMgvPWMfcmbRofBBE_FoSFxX0OmSTVDG06Jq3of2_LDI4u7NPlcn855-QQcgx0DjTn54tla-ZIKcwRUOyQCeQMMyhR7JIJpVRkVCLdJwcpLYdV0lLskX0AwZELMSGzP77r33yjFxfTxplnHXxq0lQHO9WrVe2N7nwb0hH5Uek6uZ-beUj-3t48Xt9nD7_vfl1fPWSGl6zLNEiHBqHQlnNdCFM6gxatLYVFBOGstFUOVYULa6VkFDhzBWoqhKkqlrNDcrnWXfWLxlnjQhd1rVZxSBjfVau9-n4J_lk9ta8KWcGkpIPAbCMQ25fepU41PhlX1zq4tk9KIMuhoKPT6T_gsu1jGD6nEKUsBOcjNF9DJrYpRVd9JgGqxv7V2L8a-1dj_8ODk6_5t_im8AE42wA6GV1XUQfj05ZjnHOA0fl8zaXhFJ5c3Mb7j_UH4RudeA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229967445</pqid></control><display><type>article</type><title>Rituximab: mechanisms and applications</title><source>MEDLINE</source><source>Nature Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Johnson, P W M ; Glennie, M J</creator><creatorcontrib>Johnson, P W M ; Glennie, M J</creatorcontrib><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1054/bjoc.2001.2127</identifier><identifier>PMID: 11742477</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Antibodies ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; Antineoplastic agents ; Antineoplastic Agents - therapeutic use ; Apoptosis ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cancer therapies ; Cell cycle ; Cell growth ; Cytotoxicity ; Drug Resistance ; Epidemiology ; Humans ; Immunotherapy ; Kinases ; Lymphoma ; Lymphoma, B-Cell - drug therapy ; Medical research ; Medical sciences ; Molecular Medicine ; Oncology ; Pharmacology. Drug treatments ; Regular ; regular-article ; Rituximab ; Treatment Outcome</subject><ispartof>British journal of cancer, 2001-11, Vol.85 (11), p.1619-1623</ispartof><rights>The Author(s) 2001</rights><rights>2002 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Nov 2001</rights><rights>Copyright © 2001 Cancer Research Campaign 2001 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-a19e2c216ad44a67c8ec2d2dd87d2217ed9df51ff2bdd9930143e62a077cff353</citedby><cites>FETCH-LOGICAL-c483t-a19e2c216ad44a67c8ec2d2dd87d2217ed9df51ff2bdd9930143e62a077cff353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363990/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363990/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,41467,42536,51297,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13444115$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11742477$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnson, P W M</creatorcontrib><creatorcontrib>Glennie, M J</creatorcontrib><title>Rituximab: mechanisms and applications</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><subject>Antibodies</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Cytotoxicity</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Kinases</subject><subject>Lymphoma</subject><subject>Lymphoma, B-Cell - drug therapy</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Pharmacology. Drug treatments</subject><subject>Regular</subject><subject>regular-article</subject><subject>Rituximab</subject><subject>Treatment Outcome</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kN1L5DAUxYO46Kj76qMMgvPWMfcmbRofBBE_FoSFxX0OmSTVDG06Jq3of2_LDI4u7NPlcn855-QQcgx0DjTn54tla-ZIKcwRUOyQCeQMMyhR7JIJpVRkVCLdJwcpLYdV0lLskX0AwZELMSGzP77r33yjFxfTxplnHXxq0lQHO9WrVe2N7nwb0hH5Uek6uZ-beUj-3t48Xt9nD7_vfl1fPWSGl6zLNEiHBqHQlnNdCFM6gxatLYVFBOGstFUOVYULa6VkFDhzBWoqhKkqlrNDcrnWXfWLxlnjQhd1rVZxSBjfVau9-n4J_lk9ta8KWcGkpIPAbCMQ25fepU41PhlX1zq4tk9KIMuhoKPT6T_gsu1jGD6nEKUsBOcjNF9DJrYpRVd9JgGqxv7V2L8a-1dj_8ODk6_5t_im8AE42wA6GV1XUQfj05ZjnHOA0fl8zaXhFJ5c3Mb7j_UH4RudeA</recordid><startdate>20011130</startdate><enddate>20011130</enddate><creator>Johnson, P W M</creator><creator>Glennie, M J</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20011130</creationdate><title>Rituximab: mechanisms and applications</title><author>Johnson, P W M ; Glennie, M J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-a19e2c216ad44a67c8ec2d2dd87d2217ed9df51ff2bdd9930143e62a077cff353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Antibodies</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Cytotoxicity</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Kinases</topic><topic>Lymphoma</topic><topic>Lymphoma, B-Cell - drug therapy</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Pharmacology. Drug treatments</topic><topic>Regular</topic><topic>regular-article</topic><topic>Rituximab</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnson, P W M</creatorcontrib><creatorcontrib>Glennie, M J</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnson, P W M</au><au>Glennie, M J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rituximab: mechanisms and applications</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2001-11-30</date><risdate>2001</risdate><volume>85</volume><issue>11</issue><spage>1619</spage><epage>1623</epage><pages>1619-1623</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>11742477</pmid><doi>10.1054/bjoc.2001.2127</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 2001-11, Vol.85 (11), p.1619-1623 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2363990 |
| source | MEDLINE; Nature Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Antibodies Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic agents Antineoplastic Agents - therapeutic use Apoptosis Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Cancer therapies Cell cycle Cell growth Cytotoxicity Drug Resistance Epidemiology Humans Immunotherapy Kinases Lymphoma Lymphoma, B-Cell - drug therapy Medical research Medical sciences Molecular Medicine Oncology Pharmacology. Drug treatments Regular regular-article Rituximab Treatment Outcome |
| title | Rituximab: mechanisms and applications |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A35%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rituximab:%20mechanisms%20and%20applications&rft.jtitle=British%20journal%20of%20cancer&rft.au=Johnson,%20P%20W%20M&rft.date=2001-11-30&rft.volume=85&rft.issue=11&rft.spage=1619&rft.epage=1623&rft.pages=1619-1623&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1054/bjoc.2001.2127&rft_dat=%3Cproquest_pubme%3E72351605%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229967445&rft_id=info:pmid/11742477&rfr_iscdi=true |